查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2028 年結核病疫苗市場
市場調查報告書
商品編碼
1215700

2022-2028 年結核病疫苗市場

Tuberculosis Vaccine Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 | 商品交期: 2-3個工作天內

價格

在預測期內，全球結核病疫苗市場預計將以 8.4% 的複合年增長率顯著增長。 幾種類型的研究正在進行中，極大地支持了市場的增長。 根據世界衛生組織 2021 年世界結核病 (TB) 報告，2021 年 8 月有 25 種藥物處於 I、II 或 III 期試驗，用於治療藥物敏感的結核病、耐多藥結核病或結核病感染。事實證明， 此外，2021 年 4 月，EDCTP 和阿姆斯特丹國際衛生髮展研究所 (AIGHD) 在結核病疫苗虛擬世界論壇上發布了全球結核病疫苗研發路線圖。 它是與世界衛生組織 (WHO) 密切合作進行的。

此外，市場上的參與者也為市場的增長做出了重大貢獻。 例如，2021 年 7 月，Biofabri 和 IAVI 合作對結核病 (TB) 候選疫苗 MTBVAC 進行了功效試驗。 此外，免疫接種的副作用和政府批准疫苗所需的時間是阻礙市場增長的主要因素。 疫苗接種意識的提高和政府對疫苗接種計劃的資助增加可能會在預測期內為市場帶來新的增長機會。

結核病疫苗市場按區域劃分為北美、歐洲、亞太地區和世界其他地區。 預計亞太地區將在該市場中表現出最快的增長。 印度、中國、印度尼西亞、菲律賓和巴基斯坦等國家的肺結核病例數很高。 根據世界衛生組織的數據，到 2020 年，這些國家也將佔結核病死亡人數的 60%。 此外，複雜的政府醫療保健政策來對抗結核病和更好的醫療保健基礎設施可能會幫助北美地區在預測期內保持其市場主導地位。

內容

第 1 章報告概述

  • 當前行業分析和增長前景
  • 研究方法和工具
  • 市場細分
    • 按細分
    • 按地區細分

第 2 章市場概述和洞察

  • 調查範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 推薦
    • 總結

第三章競爭格局

  • 主要公司分析
    • 概覽
    • 財務分析
    • SWOT 分析
    • 近期趨勢
  • 關鍵戰略分析

第 4 章市場決定因素

  • 激勵因素
  • 阻礙因素
  • 商機

第 5 章市場細分

  • 全球結核病疫苗市場：按類型分類
    • 免疫治療疫苗
    • 加強疫苗
  • 全球結核病疫苗市場：按最終用戶分類
    • 醫院
    • 醫務室
    • 其他

第六章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 世界其他地方
    • 拉丁美洲
    • 中東和非洲

第七章公司簡介

  • AJ Vaccines A/S
  • China National Pharmaceutical Group Corp
  • Dr. Reddy's Laboratories Ltd.
  • GlaxoSmithKline PLC
  • GreenSignal Bio Pharma Pvt. Ltd.
  • InterVax Ltd.
  • Japan BCG Laboratory
  • Merck & Co. Inc.
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Ltd.
  • Statens Serum Institut
  • Taj Pharmaceuticals Ltd.
  • Torlak Institute of Virology.
Product Code: OMR2026756

Title:Global Tuberculosis Vaccine Market Size, Share and Trends Analysis Report, By Type (Immunotherapeutic Vaccine and Booster Vaccine), By Application (Hospitals, Clinics, and Others), Forecast Period (2022-2028).

The global tuberculosis vaccine market is anticipated to grow at a substantial CAGR of 8.4% during the forecast period. Several types of research are in pipeline which is significantly supporting the market growth. According to the WHO's global tuberculosis (TB) report 2021, 25 medicines were in Phase I, Phase II, or Phase III studies in August 2021 for the treatment of drug-susceptible TB, MDR-TB, or TB infection. Besides, in April 2021, EDCTP and the Amsterdam Institute for Global Health and Development (AIGHD) launched a global TB vaccine R&D roadmap at the Virtual Global Forum on TB Vaccines. The project was conducted in close collaboration with the World Health Organization.

In addition, the players operating in the market are also helping significantly in the growth of the market. For instance, in July 2021, Biofabri and IAVI had partnered for efficacy trials of tuberculosis (TB) vaccine candidate MTBVAC. Additionally, side effects occurring from the vaccinations and the government approval time for the vaccine are the major factors that may hinder the growth of the market. Increasing awareness about vaccination and growing government funding for vaccination programs may bring new growth opportunities to the market during the forecast period.

The global tuberculosis vaccine market is segmented based on type and application. Based on type, the market is bifurcated into immunotherapeutic vaccines and booster vaccines. Based on application, the market is further sub-categorized into hospitals, clinics, and others. The immunotherapeutic vaccines such as the immune BCG segment accounted for the highest share in the past and are also the fastest-growing segment during the forecast period.

Geographically tuberculosis vaccine market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia Pacific region will show the fastest growth in this market. Countries such as India, China, Indonesia, the Philippines, and Pakistan have a high number of TB cases. And according to the World Health Organization, these countries accounted for 60% of the total TB deaths in 2020. Moreover, sophisticated healthcare government policies toward exterminating TB, and better healthcare infrastructure may support the North American region to maintain its dominance in the market during the forecast period.

The major market players in the global tuberculosis vaccine market include Pfizer Inc., Merck & Co. Inc., Dr. Reddy's Laboratories Ltd., Novartis International AG, Sanofi SA, GlaxoSmithKline PLC, Serum Institute of India Ltd., Taj Pharmaceuticals Ltd., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.

Research Methodology

The market study of the global tuberculosis vaccine market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global tuberculosis Vaccine Market Research and Analysis by Type
  • Global tuberculosis Vaccine Market Research and Analysis by Application

The Report Covers:

  • Comprehensive research methodology of the global tuberculosis vaccine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global tuberculosis vaccine market.
  • Insights about market determinants that are stimulating the global tuberculosis vaccine market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Tuberculosis Vaccine Market by Type
    • 5.1.1. Immunotherapeutic Vaccine
    • 5.1.2. Booster Vaccine
  • 5.2. Global Tuberculosis Vaccine Market by End-User
    • 5.2.1. Hospitals
    • 5.2.2. Clinics
    • 5.2.3. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World
    • 6.4.1. Latin America
    • 6.4.2. Middle East & Africa

7. Company Profiles

  • 7.1. AJ Vaccines A/S
  • 7.2. China National Pharmaceutical Group Corp
  • 7.3. Dr. Reddy's Laboratories Ltd.
  • 7.4. GlaxoSmithKline PLC
  • 7.5. GreenSignal Bio Pharma Pvt. Ltd.
  • 7.6. InterVax Ltd.
  • 7.7. Japan BCG Laboratory
  • 7.8. Merck & Co. Inc.
  • 7.9. Novartis International AG
  • 7.10. Pfizer Inc.
  • 7.11. Sanofi SA
  • 7.12. Serum Institute of India Ltd.
  • 7.13. Statens Serum Institut
  • 7.14. Taj Pharmaceuticals Ltd.
  • 7.15. Torlak Institute of Virology.

LIST OF TABLES

  • 1. GLOBAL TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL IMMUNOTHERAPEUTIC TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL BOOSTER TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 5. GLOBAL TUBERCULOSIS VACCINE IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL TUBERCULOSIS VACCINE IN CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL TUBERCULOSIS VACCINE IN OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. NORTH AMERICAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 10. NORTH AMERICAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 11. NORTH AMERICAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 12. EUROPEAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 13. EUROPEAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 14. EUROPEAN TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 15. ASIA-PACIFIC TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 16. ASIA-PACIFIC TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 17. ASIA-PACIFIC TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 18. REST OF THE WORLD TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 19. REST OF THE WORLD TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 20. REST OF THE WORLD TUBERCULOSIS VACCINE MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL TUBERCULOSIS VACCINE MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 2. GLOBAL TUBERCULOSIS VACCINE MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 3. GLOBAL TUBERCULOSIS VACCINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 4. GLOBAL IMMUNOTHERAPEUTIC TUBERCULOSIS VACCINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 5. GLOBAL BOOSTER TUBERCULOSIS VACCINE MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 6. GLOBAL TUBERCULOSIS VACCINE IN HOSPITALS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 7. GLOBAL TUBERCULOSIS VACCINE IN CLINICS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 8. GLOBAL TUBERCULOSIS VACCINE IN OTHER END-USERS MARKET SHARE BY REGION, 2021 VS 2028 (%)
  • 9. US TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 10. CANADA TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 11. UK TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 12. FRANCE TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 13. GERMANY TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 14. ITALY TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 15. SPAIN TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. REST OF EUROPE TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. INDIA TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. CHINA TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. JAPAN TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. SOUTH KOREA TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. REST OF ASIA-PACIFIC TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD TUBERCULOSIS VACCINE MARKET SIZE, 2021-2028 ($ MILLION)